Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidin

Journal of Investigative Dermatology

Volumn 132, Issue 5, 2012, Pages 1435-1442

  Kanada, Kimberly N ^a   Nakatsuji, Teruaki ^a   Gallo, Richard L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DOXYCYCLINE; KALLIKREIN 5; KALLIKREIN RELATED PEPTIDASE; MATRIX METALLOPROTEINASE; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; FLUORESCENCE POLARIZATION; HUMAN; HUMAN TISSUE; KERATINOCYTE; LOW DRUG DOSE; PRIORITY JOURNAL; PROTEIN DEGRADATION; ROSACEA; STRATUM CORNEUM;

EID: 84859774693     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.14     Document Type: Article

References (49)

1. Beaufort N, Plaza K, Utzschneider D et al. (2010) Interdependence of kallikreinrelated peptidases in proteolytic networks. Biol Chem 391:581-7
2. Belli G, Ciaffi G, Ricci P (1968) [Blood and tissue levels of 2 antibiotics of the tetracycline group orally administered to man]. Antibiotica 6:109-15
3. Brattsand M, Egelrud T (1999) Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J Biol Chem 274:30033-40
4. Briot A, Deraison C, Lacroix M et al. (2009) Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 206:1135-47
5. Cars O, Ryan DM (1988) Concentrations of doxycycline in muscle tissue and muscle tissue fluid. Scand J Infect Dis Suppl 53:18-21
6. Caubet C, Jonca N, Brattsand M et al. (2004) Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 122:1235-44 (Pubitemid 38651099)
7. Chun YH, Yamakoshi Y, Yamakoshi F et al. (2010) Cleavage site specificity of MMP-20 for secretory-stage ameloblastin. J Dent Res 89:785-90
8. De Y, Chen Q, Schmidt AP et al. (2000) LL-37, the neutrophil granule-and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192:1069-74
9. Del Rosso JQ, Webster GF, Jackson M et al. (2007) Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol 56:791-802 (Pubitemid 46561002)
10. Egelrud T (2000) Desquamation in the stratum corneum. Acta Derm Venereol Suppl (Stockh) 208:44-5
11. Eissa A, Amodeal V, Smith CR et al. (2011) Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade. J Biol Chem 286:687-706
12. Garcia RA, Pantazatos DP, Gessner CR et al. (2005) Molecular interactions between matrilysin and the matrix metalloproteinase inhibitor doxycycline investigated by deuterium exchange mass spectrometry. Mol Pharmacol 67:1128-36 (Pubitemid 40410413)
13. Golub LM, Lee HM, Ryan ME et al. (1998) Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 12:12-26
14. Golub LM, Sorsa T, Lee HM et al. (1995) Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 22:100-9
15. Hanemaaijer R, Visser H, Koolwijk P et al. (1998) Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res 12:114-8
16. Ishida-Yamamoto A, Deraison C, Bonnart C et al. (2005) LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum. J Invest Dermatol 124:360-6 (Pubitemid 40175883)
17. Jang YH, Sim JH, Kang HY et al. (2011) Immunohistochemical expression of matrix metalloproteinases in the granulomatous rosacea compared with the non-granulomatous rosacea. J Eur Acad Dermatol Venereol 25:544-8
18. Jiang R, Shi Z, Johnson JJ et al. (2011) Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma. J Biol Chem 286:9127-35
19. Kahari VM, Saarialho-Kere U (1997) Matrix metalloproteinases in skin. Exp Dermatol 6:199-213 (Pubitemid 27421661)
20. Kang S, Cho S, Chung JH et al. (2005) Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factorkappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol 166:1691-9 (Pubitemid 40734392)
21. Kantyka T, Fischer J, Wu Z et al. (2011) Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6. Peptides 32:1187-92
22. Koczulla R, von Degenfeld G, Kupatt C et al. (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111:1665-72 (Pubitemid 38057748)
23. Korting HC, Schollmann C (2009a) Current topical and systemic approaches to treatment of rosacea. J Eur Acad Dermatol Venereol 23:876-82
24. Korting HC, Schollmann C (2009b) Tetracycline actions relevant to rosacea treatment. Skin Pharmacol Physiol 22:287-94
25. Lande R, Gregorio J, Facchinetti V et al. (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449:564-9 (Pubitemid 47525141)
26. Larrick JW, Hirata M, Balint RF et al. (1995a) Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 63:1291-7
27. Larrick JW, Hirata M, Zhong J et al. (1995b) Anti-microbial activity of human CAP18 peptides. Immunotechnology 1:65-72
28. Li DQ, Chen Z, Song XJ et al. (2004) Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest Ophthalmol Vis Sci 45:4302-11 (Pubitemid 39564654)
29. Lundwall A, Brattsand M (2008) Kallikrein-related peptidases. Cell Mol Life Sci 65:2019-38
30. McNicol GP, Douglas AS (1964) Epsilon-aminocaproic acid and other inhibitors of fibrinolysis. Br Med Bull 20:233-9
31. Meyer-Hoffert U (2009) Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases. Arch Immunol Ther Exp (Warsz) 57:345-54
32. Michael IP, Sotiropoulou G, Pampalakis G et al. (2005) Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression. J Biol Chem 280:14628-35 (Pubitemid 40562808)
33. Monk E, Shalita A, Siegel DM (2011) Clinical applications of nonantimicrobial tetracyclines in dermatology. Pharmacol Res 63:130-45
34. Morizane S, Yamasaki K, Kabigting FD et al. (2010) Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid. J Invest Dermatol 130:1297-306
35. Ohler A, Debela M, Wagner S et al. (2010) Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation. Biol Chem 391:455-60
36. Ong PY, Ohtake T, Brandt C et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151-60
37. Park HJ, Cho DH, Kim HJ et al. (2009) Collagen synthesis is suppressed in dermal fibroblasts by the human antimicrobial peptide LL-37. J Invest Dermatol 129:843-50
38. Quan T, Qin Z, Xia W et al. (2009) Matrix-degrading metalloproteinases in photoaging. J Investig Dermatol Symp Proc 14:20-4
39. Ryu O, Hu JC, Yamakoshi Y et al. (2002) Porcine kallikrein-4 activation, glycosylation, activity, and expression in prokaryotic and eukaryotic hosts. Eur J Oral Sci 110:358-65
40. Sales KU, Masedunskas A, Bey AL et al. (2010) Matriptase initiates epidermal prokallikrein activation and disease onset in a mouse model of Netherton syndrome. Nat Genet 42:676-83
41. Schauber J, Ruzicka T, Rupec RA (2008) [Cathelicidin LL-37. A central factor in the pathogenesis of inflammatory dermatoses?]. Hautarzt 59:72-4
42. Skidmore R, Kovach R, Walkder C et al. (2003) Effects of subantimicrobialdose doxycycline in the treatment of moderate acne. Arch Dermatol 139:459-64 (Pubitemid 36427610)
43. Sotiropoulou G, Pampalakis G, Diamandis EP (2009) Functional roles of human kallikrein-related peptidases. J Biol Chem 284:32989-94
44. Stefansson K, Brattsand M, Ny A et al. (2006) Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum. Biol Chem 387:761-8 (Pubitemid 43964798)
45. Uitto VJ, Firth JD, Nip L et al. (1994) Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. Ann NY Acad Sci 732:140-51
46. Voegeli R, Rawlings AV, Breternitz M et al. (2009) Increased stratum corneum serine protease activity in acute eczematous atopic skin. Br J Dermatol 161:70-7
47. Wolf WC, Evans DM, Chao L et al. (2001) A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness. Am J Pathol 159:1797-805 (Pubitemid 33062522)
48. Yamasaki K, Di Nardo A, Bardan A et al. (2007) Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 13:975-80 (Pubitemid 47222043)
49. Yamasaki K, Schauber J, Coda A et al. (2006) Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J 20:2068-80 (Pubitemid 44953906)